RevampHealth to Host CEO and CFO Webinar on Healthcare Cost Reduction With 200+ Executives Registered

FLORIDA, USA, September 30th, 2026, FinanceWire

Founder Russ Carpel will argue that health benefits have become one of the largest uncontrolled expenses on the corporate P&L, and that hospital pricing, not pharmacy spend, is the primary driver.

Russ Carpel, founder and chief executive of RevampHealth.

RevampHealth will co-host a webinar for chief executives and chief financial officers on 21 October at 2:30pm Eastern, titled "Strategies for Lower Healthcare Costs and What’s Next for the Economy." The company reports that more than 200 C-level executives from Fortune 1000 companies have already registered.

The session is co-sponsored by RevampHealth and Arthur J. Gallagher & Co. Speakers are RevampHealth founder and chief executive Russ Carpel, Charlie Gasparino of Fox Business, and Steve Moore, the former senior economic advisor to Presidents Reagan and Trump.

The subject is one Carpel has been raising with finance leadership for the better part of a decade: that employee health benefits have become one of the largest expenses on the corporate P&L, and one of the least examined by the executives responsible for it.

The Structural Problem

At most large employers, health benefits sit inside HR, advised by a commercial insurance broker. The chief financial officer, who owns every other major line of expenditure in the business, is typically absent from the process.

Carpel’s position is that this has allowed decades of cost escalation, because the brokers advising on plan design have frequently been compensated in ways that reward higher-cost programs rather than lower ones.

"For too long, brokers haven’t had the motivation or tools to deliver real savings in the self-funded market," Carpel has said of the market RevampHealth operates in.

Hospitals, Not Pharmacy

Pharmacy benefit managers have absorbed most of the political and congressional attention in recent years. Carpel identifies hospitals as the larger driver, putting drug spend at roughly 25% to 30% of claims at a typical employer, with hospitals accounting for the majority of the remainder.

Bureau of Labor Statistics figures support the direction of the argument. Between January 2000 and December 2025, the price of hospital services in the United States rose 281.4%. Overall inflation across the same period was 92.6%, and average hourly wages rose 131.1%. Hospital care has grown more expensive at roughly three times the rate of the broader economy.

The Cost of Inaction

Carpel frames the consequence in household terms. With median household income for a family of three in the United States at roughly $83,000 a year, and most large employers absorbing annual benefits increases of between 5% and 15%, he argues it is neither reasonable nor sustainable to continue passing that burden to employees.

His claim is that the trajectory changes once chief executives and finance chiefs engage with the problem directly. On his account, costs fall by at least 20% at the point of intervention, and subsequent annual increases settle between 1% and 5% rather than continuing to compound at 5% to 15%.

The Gallagher Relationship

RevampHealth has a co-brokerage arrangement with Arthur J. Gallagher & Co. Under it, Gallagher contributes market reach, administration and technology, while RevampHealth supplies self-funded program design, analytics and client support. The company focuses on sectors where benefits spend is significant relative to margin, including automotive, transportation, aviation, retail, hospitality and senior living.

Addressing the question of operating alongside a major commercial broker while criticising the model, Carpel has said the arrangement "flips that script."

RevampHealth states that the combined model saves large employers between $10 million and $100 million year on year while improving benefits, with effects on EBITDA, debt ratios and exit valuations. Carpel says the company is currently close to delivering more than $100 million in savings for a major automotive manufacturer. The figures are company-reported.

Additional Appearances

Two days before the webinar, on 19 October, Carpel is scheduled to address an AICPA conference in Nashville in front of an audience of approximately 500 chief financial officers.

RevampHealth was founded in 2014, originally as Level Funded Health, before rebranding. The company is planning a national television advertising buy in 2027 targeting the C suite.

About RevampHealth

RevampHealth is a national, commercial health insurance distribution platform focused on innovative self-insured benefit programs for Fortune 5000 employer groups nationwide. RevampHealth has a non-exclusive business relationship with Gallagher Benefit Services, Inc., and each entity operates independently and is not an agent or representative of the other.

About Arthur J. Gallagher & Co.

Arthur J. Gallagher & Co. (NYSE: AJG), based in Rolling Meadows, Illinois, is a global insurance brokerage, risk management and consulting company with operations in more than 130 countries.

Website: https://www.revamphealth.com/

Contact